Manabu Katsumata is a notable inventor based in Kanagawa-ken, Japan. He has made significant contributions to the field of chemistry, particularly in the production of taurine analogues. With a total of four patents to his name, his work has implications for various industries, including pharmaceuticals.

Latest Patents

Katsumata's latest patents focus on processes for producing amino/guanidinothiosulfonic acid. The first patent describes a method that involves treating a styrenedivinylbenzene copolymer sulfonate of amino/guanidinoethyl disulfoxide with an alkali. This process selectively elutes amino/guanidinosulfinic acid, which is then reacted in a non-aqueous solvent in the presence of a base. The final product is passed through a weakly acidic cation exchange resin column, allowing for the industrial production of high-purity hypotaurine and thiotaurine.

Career Highlights

Throughout his career, Katsumata has worked with reputable companies such as Sogo Pharmaceutical Co., Ltd. and Sugo Pharmaceutical Company Limited. His expertise in chemical processes has been instrumental in advancing the production techniques for taurine analogues.

Collaborations

Katsumata has collaborated with notable colleagues, including Tomoyasu Tashiro and Saburo Uchikuga. These partnerships have contributed to the innovative approaches he has developed in his field.

Conclusion

Manabu Katsumata's work in the production of taurine analogues showcases his innovative spirit and dedication to advancing chemical processes. His patents reflect a commitment to high-purity production methods that can benefit various industries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com